Antimicrobial Activity of Dimeric Flavonoids

Compounds Pub Date : 2024-03-22 DOI:10.3390/compounds4020011
Inês Lopes, Carla Campos, Rui Medeiros, Fátima Cerqueira
{"title":"Antimicrobial Activity of Dimeric Flavonoids","authors":"Inês Lopes, Carla Campos, Rui Medeiros, Fátima Cerqueira","doi":"10.3390/compounds4020011","DOIUrl":null,"url":null,"abstract":"Distributed throughout the environment are various microorganisms such as bacteria, fungi, parasites, and viruses. Although many are part of the human microbiome, many are pathogenic and cause infections ranging from mild to severe. In recent years, the identification of multidrug-resistant microorganisms has become a serious public health problem. The resulting infections call into question the therapeutic capacity of health systems and lead to approximately 70,000 deaths annually worldwide. The progressive resistance to antibiotics and antifungals has been a major challenge for the medical and pharmaceutical community, requiring the search for new compounds with antimicrobial properties. Several studies have demonstrated the potential of natural and synthesized flavonoids, especially the dimers of these molecules. In this review are presented many examples of dimeric flavonoids that have demonstrated antimicrobial activity against viruses, like influenza and Human Immunodeficiency Virus (HIV), protozoal infections, such as Leishmaniasis and Malaria, fungal infections by Candida albicans and Cryptococcus neoformans, and bacterial infections caused, for example, by Staphylococcus aureus and Escherichia coli. In the pursuit to find potential safe agents for therapy in microbial infections, natural dimeric flavonoids are an option not only for the antimicrobial activity, but also for the low toxicity usually associated with these compounds when compared to classic antimicrobials.","PeriodicalId":10621,"journal":{"name":"Compounds","volume":" 33","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Compounds","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/compounds4020011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Distributed throughout the environment are various microorganisms such as bacteria, fungi, parasites, and viruses. Although many are part of the human microbiome, many are pathogenic and cause infections ranging from mild to severe. In recent years, the identification of multidrug-resistant microorganisms has become a serious public health problem. The resulting infections call into question the therapeutic capacity of health systems and lead to approximately 70,000 deaths annually worldwide. The progressive resistance to antibiotics and antifungals has been a major challenge for the medical and pharmaceutical community, requiring the search for new compounds with antimicrobial properties. Several studies have demonstrated the potential of natural and synthesized flavonoids, especially the dimers of these molecules. In this review are presented many examples of dimeric flavonoids that have demonstrated antimicrobial activity against viruses, like influenza and Human Immunodeficiency Virus (HIV), protozoal infections, such as Leishmaniasis and Malaria, fungal infections by Candida albicans and Cryptococcus neoformans, and bacterial infections caused, for example, by Staphylococcus aureus and Escherichia coli. In the pursuit to find potential safe agents for therapy in microbial infections, natural dimeric flavonoids are an option not only for the antimicrobial activity, but also for the low toxicity usually associated with these compounds when compared to classic antimicrobials.
二聚黄酮类化合物的抗菌活性
环境中分布着各种微生物,如细菌、真菌、寄生虫和病毒。虽然许多微生物是人类微生物群的一部分,但其中许多是致病菌,会引起轻度到重度的感染。近年来,耐多药微生物的发现已成为一个严重的公共卫生问题。由此引发的感染使卫生系统的治疗能力受到质疑,并导致全球每年约 7 万人死亡。对抗生素和抗真菌药的逐渐耐药性一直是医学界和制药界面临的一大挑战,这就需要寻找具有抗菌特性的新化合物。一些研究已经证明了天然和合成黄酮类化合物的潜力,尤其是这些分子的二聚体。本综述介绍了许多二聚黄酮类化合物的实例,它们对流感和人类免疫缺陷病毒(HIV)等病毒、利什曼病和疟疾等原生动物感染、白色念珠菌和新型隐球菌等真菌感染以及金黄色葡萄球菌和大肠杆菌等细菌感染具有抗菌活性。在寻找治疗微生物感染的潜在安全药剂的过程中,天然二聚黄酮类化合物是一个不错的选择,不仅因为它们具有抗菌活性,还因为与传统抗菌药相比,这些化合物通常毒性较低。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.30
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信